Files
Download
Download Full Text (2.3 MB)
Description
- Articles:
- FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
- Bemotrizinol: First FDA-Approved Sunscreen Ingredient in 20 Years
- Effects of Mavacamten in Hypertrophic Cardiomyopathy
- Small Increase in Bleeding Risk With Immediate Intensive Statin Therapy and Dual Antiplatelet Therapy in Mild Ischemic Stroke
- Retatrutide for Type 2 Diabetes: The TRANSCEND-T2D-1 Phase 3 Trial
- Reimagining Insulin Therapy: Clinical Impact of CagriSema in REIMAGINE-3
- FDA Approval of Veligrotug-vvze Establishes a New IV Biologic Option for TED
- Novel Oral GLP-1 Receptor Agonist HRS-7535 Shows Promising Results in Type 2 Diabetes
- FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
- Pockets of Protection: Measles Outbreak in South Carolina Due to Undervaccination in Schools
- Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer
- Pembrolizumab Plus Belzutifan Shows Promise as New Adjuvant Option for Kidney Cancer
- Ensitrelvir Approved for Postexposure Prophylaxis (PEP) Against COVID-19 in USA
- Zongertinib Shows No Clinical Significance Interaction with Itraconazole
- Novel Botanical Moisturizer Improves Rosacea Outcomes Compared to Metronidazole
- Beyond the Standard Pathways: Centanafadine’s Role in ADHD Treatment
- Efficacy and Safety of Ecopipam for Tourette Syndrome
Publication Date
8-24-2026
Volume
23
Issue
9
Pages
10
Publisher
University of the Pacific
City
Stockton, CA
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
Recommended Citation
Pacific RxTracts, "Pacific RxTracts - August 2026" (2026). Pacific RxTracts. 18.
https://scholarlycommons.pacific.edu/rx-tracts/18